Rate of decline in kidney function and known age-of-onset or duration of type 2 diabetes

被引:15
作者
Buyadaa, Oyunchimeg [1 ,2 ]
Salim, Agus [3 ,4 ,5 ,6 ]
Morton, Jedidiah I. [1 ,2 ]
Magliano, Dianna J. [1 ,2 ]
Shaw, Jonathan E. [1 ,2 ]
机构
[1] Baker Heart & Diabet Inst, Dept Clin Diabet & Epidemiol, 99 Commercial Rd, Melbourne, Vic 3004, Australia
[2] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[3] Baker Heart & Diabet Inst, Melbourne, Vic, Australia
[4] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia
[5] Univ Melbourne, Sch Math & Stat, Melbourne, Vic, Australia
[6] La Trobe Univ, Dept Math & Biostat, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
CONTROL CARDIOVASCULAR RISK; RENAL-DISEASE; YOUNG; MORTALITY; EPIDEMIOLOGY; ADOLESCENTS; PREVALENCE; MELLITUS; OUTCOMES;
D O I
10.1038/s41598-021-94099-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The association between rate of kidney function decline and age-of-onset or duration of diabetes has not been well investigated. We aimed to examine whether rates of estimated glomerular filtration rate (eGFR) decline differ by age-of-onset or duration in people with type 2 diabetes. Using the Action to Control Cardiovascular Risk in Diabetes study which included those with HbA1c >= 7.5% and who were at high risk of cardiovascular events,, rates of eGFR decline were calculated and were compared among groups defined by the known age-of-onset (0-39, 40-49, 50-59, 60-69 and>70 years) and 5-year diabetes duration intervals. Changes in renal function were evaluated using median of 6 (interquartile range 3-10) eGFR measurements per person. eGFR decline was the slowest in those with known age-at-diagnosis of 50-59 years or those with duration of diabetes<5 years. The rates of eGFR decline were significantly greater in those with known age-of-onset<40 years or those with duration of diabetes>20 years compared to those diagnosed at 50-59 or those with duration of diabetes<5 years (- 1.98 vs - 1.61 mL/min/year; - 1.82 vs - 1.52 mL/min/year; respectively (p<0.001). Those with youngest age-of-onset or longer duration of diabetes had more rapid declines in eGFR compared to those diagnosed at middle age or those with shorter duration of diabetes.
引用
收藏
页数:8
相关论文
共 24 条
[1]   Joint modelling of repeated measurement and time-to-event data: an introductory tutorial [J].
Asar, Oezguer ;
Ritchie, James ;
Kalra, Philip A. ;
Diggle, Peter J. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (01) :334-344
[2]   Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial [J].
Bjornstad, Petter ;
Nehus, Edward ;
El Ghormli, Laure ;
Bacha, Fida ;
Libman, Ingrid M. ;
McKay, Siripoom ;
Willi, Steven M. ;
Laffel, Lori ;
Arslanian, Silva ;
Nadeau, Kristen J. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (01) :65-74
[3]   Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience [J].
Bonds, D. E. ;
Craven, T. E. ;
Buse, J. ;
Crouse, J. R. ;
Cuddihy, R. ;
Elam, M. ;
Ginsberg, H. N. ;
Kirchner, K. ;
Marcovina, S. ;
Mychaleckyj, J. C. ;
O'Connor, P. J. ;
Sperl-Hillen, J. -A. .
DIABETOLOGIA, 2012, 55 (06) :1641-1650
[4]   Action to control cardiovascular risk in diabetes (ACCORD) trial: Design and methods [J].
Buse, John B. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A) :21I-33I
[5]   Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes [J].
Buyadaa, Oyunchimeg ;
Magliano, Dianna J. ;
Salim, Agus ;
Koye, Digsu N. ;
Shaw, Jonathan E. .
DIABETES CARE, 2020, 43 (01) :122-129
[6]   Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis [J].
Chan, Juliana C. N. ;
Lau, Eric S. H. ;
Luk, Andrea O. Y. ;
Cheung, Kitty K. T. ;
Kong, Alice P. S. ;
Yu, Linda W. L. ;
Choi, Kai-Chow ;
Chow, Francis C. C. ;
Ozaki, Risa ;
Brown, Nicola ;
Yang, Xilin ;
Bennett, Peter H. ;
Ma, Ronald C. W. ;
So, Wing-Yee .
AMERICAN JOURNAL OF MEDICINE, 2014, 127 (07) :616-624
[7]   Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes [J].
Gerstein, Hertzel C. ;
Beavers, Daniel P. ;
Bertoni, Alain G. ;
Bigger, J. Thomas ;
Buse, John B. ;
Craven, Timothy E. ;
Cushman, William C. ;
Fonseca, Vivian ;
Geller, Nancy L. ;
Giddings, Stephen J. ;
Grimm, Richard H., Jr. ;
Genuth, Saul ;
Hramiak, Irene ;
Ismail-Beigi, Faramarz ;
Jimenez, Carlos R. Lopez ;
Kirby, Ruth ;
Probstfield, Jeffrey ;
Riddle, Matthew C. ;
Seaquist, Elizabeth R. ;
Friedewald, William T. .
DIABETES CARE, 2016, 39 (05) :701-708
[8]  
Henderson R, 2000, Biostatistics, V1, P465, DOI 10.1093/biostatistics/1.4.465
[9]   Complications in young adults with early-onset type 2 diabetes - Losing the relative protection of youth [J].
Hillier, TA ;
Pedula, KL .
DIABETES CARE, 2003, 26 (11) :2999-3005
[10]   Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial [J].
Ismail-Beigi, Faramarz ;
Craven, Timothy ;
Banerji, Mary Ann ;
Basile, Jan ;
Calles, Jorge ;
Cohen, Robert M. ;
Cuddihy, Robert ;
Cushman, William C. ;
Genuth, Saul ;
Grimm, Richard H., Jr. ;
Hamilton, Bruce P. ;
Hoogwerf, Byron ;
Karl, Diane ;
Katz, Lois ;
Krikorian, Armand ;
O'Connor, Patrick ;
Pop-Busui, Rodica ;
Schubart, Ulrich ;
Simmons, Debra ;
Taylor, Harris ;
Thomas, Abraham ;
Weiss, Daniel ;
Hramiak, Irene .
LANCET, 2010, 376 (9739) :419-430